OpGen (OPGN) Short Interest

View and export this data going back to 2015. Start your Free Trial

What is OpGen Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of OpGen's Short Interest

For the Medical Devices subindustry, OpGen's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OpGen's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OpGen's Short Interest distribution charts can be found below:

* The bar in red indicates where OpGen's Short Interest falls into.

OpGen (OPGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OpGen Inc (NAS:OPGN) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

650:Germany

Address

9717 Key West Avenue, Suite 100, Rockville, MD, USA, 20850

Website

https://www.opgen.com

OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.

Executives

Yvonne Schlaeppi	director	600 EAST GREENWICH AVENUE, WEST WARWICK X1 02893
Johannes Bacher	officer: Chief Operating Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Albert Weber	officer: Chief Finanical Officer	MARIENBURGER STR. 7, BERLIN 2M 10405
Oliver Schacht	director, officer: Chief Executive Officer	9717 KEY WEST AVENUE, SUITE 101, ROCKVILLE MD 20850
Evan/ Fa Jones	director, officer: Chief Executive Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
William E. Rhodes	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Curetis N.v. In Liquidation	10 percent owner	MAX-EYTH-STRASSE 42, HOLZGERLINGEN 2M 71088
Mario Crovetto	director	C/O OPGEN, INC., 9717 KEY WEST AVE., SUITE 100, ROCKVILLE MD 20850
Prabhavathi Fernandes	director	114 MILTON AVENUE, CHAPEL HILL NC 27514
Vadim M. Sapiro	officer: Chief Information Officer	C/O OPGEN, INC,, 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
Timothy C Dec	officer: Chief Financial Officer	C/O OPGEN, INC., 708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG MD 20878
R Don Elsey	director	2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Jven Capital, Llc	10 percent owner	P.O. BOX 60207, POTOMAC MD 20859
Tina Susan Nova	director	C/O ARENA PHARMACEUTICALS, INC., 6166 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
Harry J D'andrea	director	6480 DOBBIN ROAD, COLUMBIA MD 21045